4.7 Article

The Role of the Unfolded Protein Response on Renal Lipogenesis in C57BL/6 Mice

期刊

BIOMOLECULES
卷 11, 期 1, 页码 -

出版社

MDPI
DOI: 10.3390/biom11010073

关键词

kidney; ER stress; lipogenesis

资金

  1. Fondo Sectorial de investigacion para ciencia basica [CB-476 2010-155700]
  2. Fondo Sectorial de Investigacion para la Educacion CB [A1-S41077/SEP/CONACYT]

向作者/读者索取更多资源

The study demonstrates that pharmacological induction of ER stress in mice leads to kidney structural abnormalities, in situ lipid synthesis, renal lipid accumulation, and functional alterations. Future strategies should focus on targeting renal ER stress to prevent kidney damage and metabolic diseases.
Renal injury observed in several pathologies has been associated with lipid accumulation in the kidney. While it has been suggested that the accumulation of renal lipids depends on free fatty acids released from adipose tissue, it is not known whether in situ renal lipogenesis due to endoplasmic reticulum (ER) stress contributes to kidney injury. The aim of the present study was to elucidate the role of pharmacological ER stress in renal structure and function and its effect on renal lipid metabolism of C57BL/6 mice. ER stress increased serum creatinine and induced kidney structural abnormalities. Tunicamycin-administered mice developed hyperinsulinemia, augmented lipolysis and increased circulating leptin and adiponectin. Renal unfolded protein response (UPR) gene expression markers, the lipogenic transcription factor SREBP1 and the phosphorylation of eIF2 alpha increased 8 h after tunicamycin administration. At 24 h, an increase in BiP protein content was accompanied by a reduction in p-eIF2 alpha and increased SREBP-1 and FASn protein content, in addition to a significant increase in triglyceride content and a reduction in AMPK. Thus, ER stress induces in situ lipid synthesis, leading to renal lipid accumulation and functional alterations. Future pharmacological and/or dietary strategies must target renal ER stress to prevent kidney damage and the progression of metabolic diseases.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据